3 ms·
> a lot of it comes down to Mylan choosing to price the drug that way. Because the FDA is killing off any competitors. Did you read the link?
by wyager 10y ago
> a lot of it comes down to Mylan choosing to price the drug that way.
Because the FDA is killing off any competitors. Did you read the link?
- maxerickson 10y agoI mention a competitor in the first sentence of my comment! Feel free to complain about the substitution rules surrounding Epipen prescriptions, but it's clearly a competitor in the sense you invoke with killing off any competitors. It's the same dose of the same drug intended for use in the same situations.